Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Dysmetria, Ataxia, Delayed fine motor development, and Intellectual disability and others; and common findings: Strabismus, Seizure, Oculomotor apraxia, and Clinodactyly and others. 34 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Inability to walk, Dystonia, Seizure |
CACNA1G encodes calcium voltage-gated channel subunit alpha1 G (2,377 aa). Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. Highest expression in Brain Cerebellum (32.6 TPM) and Cervix Ectocervix (19.4 TPM).
Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits is associated with mutations in the CACNA1G gene on chromosome 17.
CACNA1G is classified as a druggable target (Druggable Genome and Ion Channel categories) with score 2.2.
Genetic testing for CACNA1G is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 6 common features.
No clinical trials have been registered for spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits.
4 publications have been identified in PubMed for spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits. Research spans Review / Meta-Analysis (50%) and Basic Science / Preclinical (50%).
Davakan A (2025). [PMID: 41111510](https://pubmed.ncbi.nlm.nih.gov/41111510/). *Front Pharmacol*. [Basic Science / Preclinical]
Qebibo L (2025). [PMID: 39674904](https://pubmed.ncbi.nlm.nih.gov/39674904/). *Genet Med*. [Basic Science / Preclinical]
Rudaks LI (2024). [PMID: 38760634](https://pubmed.ncbi.nlm.nih.gov/38760634/). *Cerebellum*. [Review / Meta-Analysis]
Szymanowicz O (2024). [PMID: 38785745](https://pubmed.ncbi.nlm.nih.gov/38785745/). *Diseases*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 1:32 AM UTC
Online Mendelian Inheritance in Man
Muscles |
3 |
Cerebellar vermis atrophy, Axial hypotonia, Delayed gross motor development |
Eyes | 2 | Strabismus, Oculomotor apraxia |
Head and neck | 2 | Microcephaly, Mandibular prognathia |
Arms and legs | 1 | Limb hypertonia |